FDA Releases Draft Guidance on Assessing Food Effects on Investigational New Drugs

Summary

The US Food and Drug Administration (FDA) has published a draft guidance document outlining recommendations for assessing the impact of food on the efficacy of orally administered drugs in clinical trials, as part of Investigational New Drug (IND) and New Drug Application (NDA) submissions.